Announced Wed, 19 Nov · 20:21 IST
GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about General Updates
General View source PDF
GLAXO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve
Awaiting price reaction for this filing.
AI summary
GlaxoSmithKline Pharmaceuticals Limited has submitted a general update to the National Stock Exchange. The specific nature of the update has not been detailed in the headline. The company's core business remains in pharmaceuticals, including vaccines and specialty medicines. Shareholders may need to access the full filing on the NSE portal for complete information.
Likely market impact
Without specifics on the update, immediate stock price impact is unclear. Investors should review the detailed filing to understand any potential operational, financial, or strategic implications.